Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
July 04 2019
Lyon, July 2-5th 2019: Defymed will participate to the 17th World Congress of the IPITA (INTERNATION...
May 23 2019
Lille, June 25-26th 2019: As Defymed won the “Start-up Slams” contest in MEDFIT Strasbourg last year...